Evidence map

ReviewFrontiers in bioengineering and biotechnology2026

A patent review of cyclin-dependent kinase 5 (CDK5) inhibitors (1999-2025).

Varvara M Derzhavina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42312138